0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Tumor-Induced Osteomalacia: Treatment Progress Using Burosumab, an Anti-FGF23 Monoclonal Antibody.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          J Bone Miner Res
          Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
          Wiley
          1523-4681
          0884-0431
          Apr 2021
          : 36
          : 4
          Affiliations
          [1 ] Division of Bone and Mineral Diseases, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.
          [2 ] Center for Metabolic Bone Disease and Molecular Research, Shriners Hospitals for Children-St. Louis, St. Louis, MO, USA.
          Article
          10.1002/jbmr.4280
          33740291
          e0b8945a-491a-48c1-a3fe-abac8c7ade31
          History

          Comments

          Comment on this article